OR.17. Ninjurin-1 is a Novel Adhesion Molecule of the Blood-brain Barrier Involved in the Recruitment of Monocytes to the Central Nervous System

Download
  1. Get@NRC: OR.17. Ninjurin-1 is a Novel Adhesion Molecule of the Blood-brain Barrier Involved in the Recruitment of Monocytes to the Central Nervous System (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1016/j.clim.2009.03.024
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleClinical Immunology
ISSN1521-6616
Volume131
Article numberSupplement
PagesS10S11
Subjectblood-brain barrier; Ninjurin-1; monocytes; novel adhesion molecules
AbstractIn Multiple Sclerosis (MS), inflammatory demyelinating lesions are associated with a compromised blood-brain barrier (BBB) and with perivascular infiltrations of immune cells into the central nervous system (CNS). Nerve injury-induced protein (Ninjurin)-1 was described as an adhesion molecule that promotes nerve regeneration, in a homotypic Ninjurin-Ninjurin fashion. We recently identified expression of Ninjurin-1 by human brain-derived endothelial cells (ECs) in a proteomic screen for BBB-associated proteins. The goal of this study is to elucidate the role of Ninjurin-1 in the trans-BBB migration of immune cells. We confirmed the expression of Ninjurin-1 on BBB-ECs in vitro by WB and by flow cytometry and we show regulation of Ninjurin-1 upon treatment with pro-inflammatory cytokines TNF and IFN-gamma. Furthermore, Ninjurin-1 immunoreactivity was detected in vitro on BBB-ECs and in situ in MS lesions. Ninjurin-1 was found to be present on human peripheral blood immune cells, and preferentially expressed on CD14 monocytes and CD83 dendritic cells (DCs), as compared to CD4, CD8 or CD19 lymphocytes. We further detected Ninjurin-1 expression on antigen presenting cells, such as CD11c DCs and F4/80 macrophages within the CNS of MOG-induced EAE-affected C57BL/6 mice. Finally, using a modified Boyden chamber assay, we showed that migration of ex vivo CD14 monocytes across the human endothelium is significantly reduced following treatment of BBB-ECs with a competing Ninjurin-1 blocking peptide. Our findings suggest that Ninjurin-1 is a novel adhesion molecule of the CNS endothelium that acts as a regulator of monocyte migration into the brain.
Publication date
LanguageEnglish
AffiliationNRC Institute for Biological Sciences; National Research Council Canada
Peer reviewedYes
NPARC number21275173
Export citationExport as RIS
Report a correctionReport a correction
Record identifier031904c4-bd18-453f-a9a6-4026d2c87247
Record created2015-05-22
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)